Atlas Trials

Haploidentical Hematopoietic Stem Cell Transplantation With Early ATG and Low Dose Post-transplant Cyclophosphamide

Clinical trial NCT06041893 · RECRUITING

Trial details

NCT number
NCT06041893
Sponsor
Samsung Medical Center
Status
RECRUITING
Study type
OBSERVATIONAL
Haploidentical Hematopoietic Stem Cell Transplantation
Start date
2023-05-29
Primary completion
2025-07-05
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.